As of 9:30 AM on the 24th, Celltrion is trading at 326,000 KRW, up 2.35% from the previous day. This marks a 54.5% increase compared to May 28. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Over the past five days, individual investors have net sold 283,814 shares, while foreigners and institutions have net bought 448,315 shares and net sold 146,339 shares, respectively.

On June 23, Celltrion became a market topic with the announcement of the COVID-19 improvement effects of "Remsima," described as a "bullish" development.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing